Your browser doesn't support javascript.
loading
Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients.
Rauma, Ilkka; Mustonen, Tiina; Seppä, Juha Matti; Ukkonen, Maritta; Männikkö, Marianne; Verkkoniemi-Ahola, Auli; Kartau, Marge; Saarinen, Jukka T; Luostarinen, Liisa; Simula, Sakari; Ryytty, Mervi; Ahmasalo, Riitta; Sipilä, Jussi O T; Pieninkeroinen, Ilkka; Tapiola, Tero; Remes, Anne M; Kuusisto, Hanna.
Afiliação
  • Rauma I; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. ilkka.rauma@tuni.fi.
  • Mustonen T; Department of Neurology, Tampere University Hospital, Tampere, Finland. ilkka.rauma@tuni.fi.
  • Seppä JM; Department of Neurology, Seinäjoki Central Hospital, Seinäjoki, Finland. ilkka.rauma@tuni.fi.
  • Ukkonen M; Neuro Center, Kuopio University Hospital, Kuopio, Finland.
  • Männikkö M; Department of Neurology, Satasairaala, Pori, Finland.
  • Verkkoniemi-Ahola A; Department of Neurology, Tampere University Hospital, Tampere, Finland.
  • Kartau M; Department of Neurology, Seinäjoki Central Hospital, Seinäjoki, Finland.
  • Saarinen JT; Clinical Neurosciences, Neurology, Helsinki University Hospital and Helsinki University, Helsinki, Finland.
  • Luostarinen L; Clinical Neurosciences, Neurology, Helsinki University Hospital and Helsinki University, Helsinki, Finland.
  • Simula S; Department of Neurology, Vaasa Central Hospital, Vaasa, Finland.
  • Ryytty M; Department of Neurology, Päijät-Häme Central Hospital, Lahti, Finland.
  • Ahmasalo R; Department of Neurology, Mikkeli Central Hospital, Mikkeli, Finland.
  • Sipilä JOT; Medical Research Center, Oulu University Hospital, Oulu, Finland.
  • Pieninkeroinen I; Research Unit of Clinical Neuroscience, University of Oulu, Faculty of Medicine, Oulu, Finland.
  • Tapiola T; Department of Neurology, Lapland Central Hospital, Rovaniemi, Finland.
  • Remes AM; Department of Neurology, North Karelia Central Hospital, Siun Sote, Joensuu, Finland.
  • Kuusisto H; Department of Clinical Neurosciences, University of Turku, Turku, Finland.
J Neurol ; 269(2): 824-835, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34255182
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Idioma: En Ano de publicação: 2022 Tipo de documento: Article